Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm. Adams SD, Evans JP, Aylsworth AS N C Med J. 2013 Nov-Dec; 74(6):494-8. PMID: 24316774. Abstract CommentRecommendBookmarkWatch